Navigation Links
New Cancer “Growth Blocking Super Drug” Patents Filed
Date:2/8/2013

San Diego, CA (PRWEB) February 08, 2013

The pharmaceutical world has been racing for the cure for cancer for decades with what most experts agree is limited success. The current drugs are either so toxic and damaging to the body that many patients have to weigh the benefits of their use or the drugs are only designed to treat specific types of cancers and often only specific “strains” of specific cancers.

There is now an emerging world class sprinter in the race to create the “Super Drug” – Kalos Therapeutics. The “Super Drug” in the cancer world refers to a drug that may be used to treat multiple types of cancer and their various strains while avoiding the additional trauma often caused by chemotherapy, radiation and many of the current cancer drugs.

Kalos Therapeutics is an emerging biomedical company with the exclusive patent to develop the ANP (Atrial Natriuretic Peptide) family of peptides as a new mechanism for the treatment of cancer.

Kalos is pioneering an approach to cancer treatment by developing peptides made primarily in the heart, as a cytostatic therapeutic for treating aggressive cancers by engaging known pathway receptors more efficiently without the side effects associated with chemotherapeutic or small molecule compounds.

George Colberg, the CEO of Kalos Therapeutics, has amassed a who’s who dream team representing the best and brightest of the cancer and bio-tech worlds. More importantly is the fact that the team has the ability to think differently about what is the most effective way to treat cancer. It is that difference in thinking that appears to be producing a game changing cancer therapy.

Anti-Cancer Bio-technology

“Kalos has successfully leveraged the natural antiproliferative activity of the Atrial Natriuretic Peptide (ANP) family of peptides in our pat
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. University of Colorado Cancer Center Review Shows Long-term Side-effects of New, Targeted Therapies in Pediatric Cancer Patients
2. Transcreener Assays Highlighted for Challenging Microbial, Cancer and Epigenetic Drug Targets at SLAS 2013
3. Governor Cuomo Announces Continued Growth at Roswell Park Cancer Institute with Regional Economic Development Council Funding; RPCI Center for Personalized Medicine established with CTG (NASDAQ: CTGX) serving as its technology partner
4. Transition in cell type parallels treatment response, disease progression in breast cancer
5. Two University of Colorado Cancer Center Studies Show that Silibinin, Found in Milk Thistle, Protects Against UV-Induced Skin Cancer
6. Navigating Cancer Announces Jeff Oberlander as VP, Engineering
7. Tracking the Battle Against Breast Cancer With New Market Research
8. Caris Life Sciences Adds Next-Generation Sequencing to Enhance Evidence-Based Tumor Profiling Service for Cancer Patients
9. WaferGens MyDesign Open Platform Facilitates Rapid Development of a Proprietary Prostate Cancer Diagnostic Panel in the Lab of Dr. Arul Chinnaiyan at the University of Michigan Cancer Center
10. Touch Medical Media Splits From Touch Briefings, Launches a Series of Cutting Edge, Free to Access, Educational Resources and Signs an Updated Media Partnership With ECCO, The European CanCer Organisation Representing 60,000 Oncology Professionals
11. DelMar Pharmaceuticals Announces Acquisition and $5.4 Million Private Placement to Advance Novel Cancer Therapies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... N.J. (PRWEB) May 21, 2015 ... circulation audit and been admitted to BPA Worldwide ... BPA Worldwide will track audience data for Specialty ... coverage. , “By becoming a member of ... dedication to providing our clients with the most ...
(Date:5/21/2015)... NEW YORK , May 21, 2015  Prima ... biotechnology company that is striving to become a leader ... of cancer, recently announced that the final CVac data ... has shown a clear trend for a clinically meaningful ... ("SOC") in second remission patients. In the ...
(Date:5/21/2015)... Calif. , May 21, 2015  The ... Orrin Hatch (R-UT) and Amy Klobuchar ... Extensions Now Accelerating Cures & Treatments, or OPEN ... rare disease patient advocacy organizations, this bipartisan legislation ... and affordable medicines to rare disease patients by ...
(Date:5/21/2015)... W. R. Grace & Co. ... Worms, Germany has received good manufacturing practice (GMP) ... International Pharmaceutical Excipient Council (IPEC) Foundation. ... SYLOID® FP brand of pharmaceutical grade excipient silica ... Curtis Bay, Maryland (USA) and Sorocaba, Brazil locations. ...
Breaking Biology Technology:Specialty Pharmacy Times Joins BPA Worldwide 2Correction Continues after Big Move - BrokerBank Securities, Inc. 2Advocates Cheer Senate Leaders for Introducing Bipartisan Bill to Increase Number of Rare Disease Treatments 2Grace European Facility Receives GMP Excipient Certification for SYLOID® FP Silica Gel 2
... - Alfalight, Inc. , a Madison-based manufacturer ... markets, has been awarded $1.4 million in funding for ... program, sponsored by the Defense Advanced Research Projects ... is to increase a laser's power conversion efficiency -- ...
... so-called Dog Days of summer. Business slows. Indeed, in Europe, ... a state of suspended animation that will last until the ... out for attention. Work's grasp weakens. , ,Or does it? ... to a Monday morning mountain in my inbox and a ...
... - Gov. Jim Doyle on Monday expressed hope ... Majority Leader Bill Frist's recent decision to support removal ... , ,Doyle made his comments at the groundbreaking of ... also praised Wisconsin's medical development scene. , ,In remarks ...
Cached Biology Technology:Alfalight garners $1.4 million defense funding for diode program 2Leaving it all behind 2Doyle praises Frist's new stem cell research position 2Doyle praises Frist's new stem cell research position 3
(Date:5/5/2015)... 5, 2015, NXT-ID, Inc. (NASDAQ: NXTD ) ... the growing mobile commerce market, reminds investors and media that ... is presenting  at CARTES SECURE CONNEXIONS AMERICA 2015, held in ... The three-day conference is organized into a series ... is themed Global Fraud: Where is the Trust in ...
(Date:4/21/2015)... , April 21, 2015 ... government policies are boosting access control systems market in ... According to a recently published report by TechSci Research ... ", the access control systems market in ... billion by 2020.The access control systems market in the ...
(Date:4/14/2015)... , April 14, 2015  HYPR Corp. ... Online (FIDO ® ) Alliance tm , an ... FIDO members commit to share technology and collaborate ... that are interoperable, more secure and private, and ... biometric identity verification that protects sensitive user information ...
Breaking Biology News(10 mins):NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 3Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 2Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 3HYPR Corp. Joins the FIDO Alliance 2HYPR Corp. Joins the FIDO Alliance 3
... touted for its beneficial effects on a range of human ... developing certain cancers. But it does not improve cholesterol levels, ... Hospital. A team of scientists has shown that, at least ... volunteers with vitamin D deficiency received mega-doses of vitamin D. ...
... Donald Danforth Plant Science Center will be hosting its ... Friday, September 28th, 2012. This year,s symposium will feature ... will present on a wide range of topics on ... synthetic and systems level explorations in biology that are ...
... three quarters of disposed electrical household appliances in Spain ... (SIG). A study at the University of Salamanca exposes ... waste management system and avoid payment. According to ... manufacturers of such products should recycle the waste they ...
Cached Biology News:Vitamin D supplements do not improve cholesterol as previous research suggested 2Danforth Plant Science Center hosts 14th Annual Fall Symposium 2More than 70% of electronic waste management is uncontrolled 2More than 70% of electronic waste management is uncontrolled 3
5 minutes from gel band to purified DNA...
Collected from sexually matured, mixed breed, mixed sex guinea pigs....
Sterile concentration of Dithiothreitol (DTT) solution in phosphate buffer (pH 7.0). Dilute contents in one vial (10- fold) to 100 ml. For use in liquefying sputum samples....
Antibody specific for phosphorylattion of histone H3 that occurs during mitosis. Rabbit polyclonal serum. Antigen: Synthetic peptides derived from histone H3, phosphorylated at serines 10 or 28...
Biology Products: